EUCTR2011-004951-38-IT进行中（未招募）不适用
Role of PET/CT with 18F-choline in biochemical relapse in prostate cancer patients treated with radical intent. Pet Col study. - Pet-Col
AZIENDA USL DI FORLI'0 个研究点开始时间: 2011年12月22日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •- previous prostate cancer radically treated - PSA>1 ng/ml with an increase of at least 20% in the last 3-6 months - =18 years - written informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 40
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 60
排除标准
- •- PSA<1 ng/ml - psichiatric disease
研究者
相似试验
进行中（未招募）
1 期
Role of PET/ CT with 18F-fluorocholine in the staging of patients with intermediate/high risk prostate cancer.EUCTR2013-002511-99-ITISTITUTO ONCOLOGICO VENETO390
进行中（未招募）
1 期
Prospective comparison of 18F-choline PET/CT and 18F-FDG PET/CT in the initial work-up of Multiple MyelomaMultiple myelomaMedDRA version: 20.0 Level: LLT Classification code 10028228 Term: Multiple myeloma System Organ Class: 100000004864EUCTR2018-003926-10-FRCHU de Bordeaux30
已完成
不适用
Diagnostic Value of 18F-Choline PET/CT in Patients With a Thyroid Nodule With an Indeterminate Cytology: Pilot StudyThyroid GlandNCT02784223Centre Francois Baclesse107
进行中（未招募）
不适用
study for evaluation of 18F-choline PET/CT efficacy in patients with prostate carcinoma. - NDEUCTR2010-021501-20-ITISTITUTO NEUROLOGICO MEDITERRANEO NEUROMED
撤回
不适用
Study of 18F-FEC for Positron Emission Tomography-Computed Tomography (PET-CT) Imaging of GBMAstrocytoma, Grade IVGiant Cell GlioblastomaGlioblastoma MultiformeNCT00943462Centre hospitalier de l'Université de Montréal (CHUM)